Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Open in API
Filings indexed 241 across all filing types
Latest filing 2023-05-16 AGM Information
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company Voronoi. It details the date, time, location, and the specific agenda items (amendment of articles of incorporation and appointment of directors). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2023-05-16 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2023-05-16 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing (amendment/correction) regarding the convocation of an Extraordinary General Meeting (EGM). It details the agenda items, specifically the appointment of directors (Kim Nam-doo and Choi Hwan-geun), and corrects the meeting time. Since this document provides the specific agenda and proxy-related information for a shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI).
2023-05-16 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Voronoi Inc. (보로노이주식회사) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-11 Korean
합병등종료보고서(합병)
M&A Activity Classification · 100% confidence The document is a 'Merger Completion Report' (합병등종료보고서) filed by Voronoi Inc. with the Financial Supervisory Service (FSS) in South Korea. It details the finalization of a merger process, including the timeline, creditor protection procedures, and post-merger financial summaries. Since this document pertains to corporate restructuring and M&A activity, it falls under the M&A Activity category.
2023-05-11 Korean
기타경영사항(자율공시)(소규모합병 승인 이사회 결의(주주총회 갈음) 결과 보고)
AGM Information Classification · 100% confidence The document is a regulatory filing from Voronoi regarding the results of a board resolution for a small-scale merger (absorption of Voronoi Bio). It details the merger process, the lack of shareholder opposition, and the finalization of the merger. Since this document describes a specific corporate merger activity and its outcome, it falls under M&A Activity (TAR).
2023-05-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.